Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Nat Med. 2019 Oct 7;25(10):1549–1559. doi: 10.1038/s41591-019-0592-2

Extended Data Fig. 1. Patient selection, mutational burden and clinical characteristics.

Extended Data Fig. 1

a, CONSORT diagram showing the selection of TRACERx patients for TCR sequencing. b, The total number of nonsynonymous mutations (clonal and subclonal) and patient clinical characteristics (histology, stage, smoking status and clinical outcome) for the TCR sequencing cohort are shown.